Masimo Corporation  

(Public, NASDAQ:MASI)   Watch this stock  
Find more results for MASI
93.94
+0.65 (0.70%)
Jun 23 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 92.93 - 94.03
52 week 48.07 - 104.71
Open 93.42
Vol / Avg. 379,116.00/497,088.00
Mkt cap 4.87B
P/E 16.00
Div/yield     -
EPS 5.87
Shares 51.46M
Beta 0.88
Inst. own 83%
Aug 1, 2017
Q2 2017 Masimo Corp Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jun 1, 2017
Masimo Corp Annual Shareholders Meeting
May 9, 2017
Masimo Corp Investor Day 2017 - Webcast
May 3, 2017
Q1 2017 Masimo Corp Earnings Call - Webcast
May 3, 2017
Q1 2017 Masimo Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Apr '17) 2016
Net profit margin 24.33% 43.28%
Operating margin 23.19% 60.58%
EBITD margin - 24.13%
Return on average assets 21.42% 42.28%
Return on average equity 30.45% 71.96%
Employees 1,243 -
CDP Score - -

Address

52 Discovery
IRVINE, CA 92618-3105
United States - Map
+1-949-2977000 (Phone)
+1-949-2977499 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company's business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include non-invasive monitoring of blood constituents with an optical signature, optical organ oximetry monitoring, electrical, brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring. In addition, the Company has developed the Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor, and the Radius-7 wearable wireless patient monitor. It offers Patient SafetyNet remote patient surveillance monitoring system, which allows patients to be monitored through a personal computer-based monitor or by care providers through their pagers, voice-over-Internet Protocol (IP) phones or smartphones.

Officers and directors

Joseph E. Kiani Chairman of the Board, Chief Executive Officer
Age: 52
Bio & Compensation  - Reuters
Mark P. de Raad Chief Financial Officer, Executive Vice President - Finance
Age: 57
Bio & Compensation  - Reuters
Jon Coleman President - Worldwide Sales, Professional Services and Medical Affairs
Age: 53
Bio & Compensation  - Reuters
Rick Fishel President - Worldwide OEM Business & Strategic Development
Age: 59
Bio & Compensation  - Reuters
Anand Sampath Chief Operating Officer
Age: 50
Bio & Compensation  - Reuters
Yongsam Lee Executive Vice President, Chief Information Officer
Age: 52
Bio & Compensation  - Reuters
Tom McClenahan Executive Vice President, General Counsel, Corporate Secretary
Age: 44
Bio & Compensation  - Reuters
Steven J. Barker M.D., Ph.D. Director
Age: 72
Bio & Compensation  - Reuters
Sanford Fitch Independent Director
Age: 76
Bio & Compensation  - Reuters
Thomas Harkin Independent Director
Age: 77
Bio & Compensation  - Reuters